INBX· Inhibrx Biosciences Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 5 quarters
INBX Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$2.0B
Enterprise value$1.9B
EV / EBITDA (TTM)-14.68
P/E ratio (TTM)—
Forward P/E-48.15
P/S ratio1509.61
P/B ratio245.16
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$130M
Free cash flow (TTM)-$84M
Total cash$124M
Total debt$107M
Debt / equity1338.82
Current ratio3.93
Income Statement
Total revenue (TTM)$1M
Revenue per share (TTM)0.08
Gross profit (TTM)-$112M
EBITDA (TTM)-$133M
Net income (TTM)-$140M
EPS diluted (TTM)-9.04
Shares outstanding14,607,286
Float shares7,805,416
Profitability
Gross margin0.00%
Operating margin-10386.54%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-51.58%
Return on equity (TTM)-197.85%
Price History
Current price$134.35
52 Week high$155.29
52 Week low$10.84
50 day average$85.94
200 day average$64.25
Average volume (10 day)491,310
1-year beta—
1-year price target$300.00
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:38 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com